- Home
- ASTI vs NCNA Comparison
ASTI vs NCNA Comparison
Compare ASTI & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- NCNA
- Stock Information
- Founded
- ASTI 2005
- NCNA 1997
- Country
- ASTI United States
- NCNA United Kingdom
- Employees
- ASTI N/A
- NCNA N/A
- Industry
- ASTI Semiconductors
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- NCNA Health Care
- Exchange
- ASTI Nasdaq
- NCNA Nasdaq
- Market Cap
- ASTI 6.7M
- NCNA 7.6M
- IPO Year
- ASTI N/A
- NCNA 2017
- Fundamental
- Price
- ASTI $1.67
- NCNA $3.41
- Analyst Decision
- ASTI
- NCNA
- Analyst Count
- ASTI 0
- NCNA 0
- Target Price
- ASTI N/A
- NCNA N/A
- AVG Volume (30 Days)
- ASTI 571.3K
- NCNA 205.1K
- Earning Date
- ASTI 11-10-2025
- NCNA 11-13-2025
- Dividend Yield
- ASTI N/A
- NCNA N/A
- EPS Growth
- ASTI N/A
- NCNA N/A
- EPS
- ASTI N/A
- NCNA N/A
- Revenue
- ASTI $61,134.00
- NCNA N/A
- Revenue This Year
- ASTI N/A
- NCNA N/A
- Revenue Next Year
- ASTI N/A
- NCNA N/A
- P/E Ratio
- ASTI N/A
- NCNA N/A
- Revenue Growth
- ASTI 36.85
- NCNA N/A
- 52 Week Low
- ASTI $1.10
- NCNA $2.78
- 52 Week High
- ASTI $4.41
- NCNA $330.00
- Technical
- Relative Strength Index (RSI)
- ASTI 37.63
- NCNA 38.82
- Support Level
- ASTI $1.58
- NCNA $3.55
- Resistance Level
- ASTI $1.75
- NCNA $3.86
- Average True Range (ATR)
- ASTI 0.18
- NCNA 0.28
- MACD
- ASTI -0.04
- NCNA -0.05
- Stochastic Oscillator
- ASTI 28.75
- NCNA 16.67
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.